标题
Avelumab: A Review in Metastatic Merkel Cell Carcinoma
作者
关键词
-
出版物
Targeted Oncology
Volume 13, Issue 3, Pages 409-416
出版商
Springer Nature
发表日期
2018-05-24
DOI
10.1007/s11523-018-0571-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials
- (2018) Karen Kelly et al. CANCER
- Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
- (2018) Sandra P. D’Angelo et al. JAMA Oncology
- Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial
- (2018) Howard L. Kaufman et al. Journal for ImmunoTherapy of Cancer
- Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs
- (2017) Dirk Schadendorf et al. EUROPEAN JOURNAL OF CANCER
- Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma
- (2017) Paul Nghiem et al. Future Oncology
- Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA
- (2017) C Lance Cowey et al. Future Oncology
- Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial
- (2017) Christopher R Heery et al. LANCET ONCOLOGY
- Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy
- (2017) Teresa Amaral et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe
- (2017) Jürgen C. Becker et al. Oncotarget
- Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis
- (2017) Peng-Fei Wang et al. Frontiers in Pharmacology
- Merkel cell carcinoma
- (2017) Jürgen C. Becker et al. Nature Reviews Disease Primers
- Analysis of Prognostic Factors from 9387 Merkel Cell Carcinoma Cases Forms the Basis for the New 8th Edition AJCC Staging System
- (2016) Kelly L. Harms et al. ANNALS OF SURGICAL ONCOLOGY
- Merkel Cell Carcinoma Therapeutic Update
- (2016) Nicole M. Cassler et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
- (2016) Howard L Kaufman et al. LANCET ONCOLOGY
- PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune Responses
- (2016) Patrick J. Medina et al. PHARMACOTHERAPY
- Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab
- (2016) Rika Fujii et al. Oncotarget
- Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma
- (2016) Jayasri G. Iyer et al. Cancer Medicine
- Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline
- (2015) Celeste Lebbe et al. EUROPEAN JOURNAL OF CANCER
- Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
- (2015) B. Boyerinas et al. Cancer Immunology Research
- Merkel Polyomavirus-Specific T Cells Fluctuate with Merkel Cell Carcinoma Burden and Express Therapeutically Targetable PD-1 and Tim-3 Exhaustion Markers
- (2013) O. K. Afanasiev et al. CLINICAL CANCER RESEARCH
- PD-L1 Expression in the Merkel Cell Carcinoma Microenvironment: Association with Inflammation, Merkel Cell Polyomavirus, and Overall Survival
- (2013) E. J. Lipson et al. Cancer Immunology Research
- The Role of the Immune Response in Merkel Cell Carcinoma
- (2013) Pierre Triozzi et al. Cancers
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now